Doctors serve needs on both sides of the bargaining table

Improving patient monitoring through care-at-home services could help reduce maternal mortality, they say.

More needs to be done to give healthcare access to low-income women.

FDA approves several drugs to treat rare conditions in both cancer and metabolic diseases.

Actions from FDA this week include approval of a second targted treatment for a Duchenne muscular dystrophy mutation, and filings in COVID-19 and blood disorders.

Adaptive Biotechnologies’ clonoSEQ gets third approval; FDA also acts on first at-home treatment for spinal muscular atrophy.

This month’s featured exec is Deborah Feldman, president and CEO of Dayton Children’s Hospital. Here, she sheds light on how the future of healthcare is shaping up, and how value-based care, the ACA, and pediatric pain management fit in.